Philippine Health Research Registry
Display Options
Results List
Results 1 - 11 of 11 research(es) registered in August 2017

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Pending
Project Description:
The study aims to assess the effect of drug allergy educational program and antibiotic prescribing and skin testing guideline on inpatient healthcare providers’ knowledge regarding antibiotic prescribing and skin testing in the Philippine General Hospital (PGH). PGH is considered one of the largest hospital and best referral center in the country... [read more]
Project Status:
Ongoing
Project Description:
The Development a Diagnosis Relate Group (DRG) system based Global Budget Payment (GBP) mechanism is a policy research that aims to provide empirical evidence on how this change in Provider Payment Mechanism (PPM) will affect PhilHealth payouts to facilities. This study aims to demonstrate theoretically, the potential changes that PhilHealth co... [read more]
Project Status:
Ongoing
Project Description:
The drug being tested in this study is called sIPV. sIPV is used to prevent poliomyelitis. This study will look at the safety, tolerability of sIPV in healthy adults, toddlers and infants as well as immunogenicity in toddlers and infants. .   The study will enroll approximately 340 participants including 40 adults, 60 toddlers and 240 infants. Adu... [read more]
Project Status:
Ongoing
Project Description:
non-interventional, multicenter, prospective, parallel group studyPatients starting a new treatment with a biologic agent or conventional systemic therapy for chronic plaque psoriasis (both treatment-naïve or switching to a different drug) are eligible for participation... [read more]
Project Status:
Ongoing
Project Description:
This is a Phase 3, multicenter, randomized, prospective, double-blind, parallel-group, placebo-controlled, 2-arm comparison study of Orelvo versus matching placebo. Subjects who have provided a signed and dated informed consent will be screened into the study up to 30 days before randomization. During the screening period, eligibility criteria will... [read more]
Project Status:
Ongoing
Project Description:
The discount cards study will describe perceptions of both physicians and patients with regard to its advantages and disadvantages in terms of managing patient’s health. 
Project Status:
Pending
Project Description:
This is a Phase 3, multicenter, randomized, masked, controlled, parallel group study of 12 months duration in treatment-naïve subjects with RVO. This study is projected to enroll approximately 460 subjects, randomly assigned 1:1 to one of two treatment groups stratified by disease (BRVO, CRVO). Randomization will proceed as described until either ... [read more]
Project Status:
Ongoing
Project Description:
This is an observational cohort study that will track intubated adult patients in Charity Wards and Intensive Care units in order to detect occurrence of unplanned extubations. Circumstances surrounding the extubation will be described as well as the outcomes post-extubation.... [read more]
Project Status:
Ongoing
Project Description:
This study is a multi-national, multi-center, double-blind, randomized, active controlled, parallel-group Phase II/III (Stage I & Stage II) seamless study designed to evaluate the safety and immunogenicity of “LBVC (Sabin Poliomyelitis Vaccine(Inactivated))” compared with “Imovax® Polio (Poliomyelitis Vaccine(Inactivated))” given with ... [read more]
Project Status:
Ongoing
Project Description:
This study is an open-label randomized Phase II/III study of dinutuximab and irinotecan compared to irinotecan alone with an intrasubject dose-escalation lead-in phase in subjects with relapsed or refractory SCLC.   A total of approximately 10 subjects with SCLC will be enrolled in the intrasubject dose escalation phase, referred to as Part 1. Ph... [read more]
Project Status:
Ongoing
Project Description:
Over the years, the AOs in the DOH have accumulated and the department is unable to monitor the changes in provisions that have occurred. Moreover, there is no system in identifying duplications, inconsistencies, and gaps within the policies. Explicitly or implicitly repealed AOs are subsequently not updated and can be a cause of confusion. Thus, t... [read more]